se ha leído el artículo
array:24 [ "pii" => "S1578219018303615" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.10.007" "estado" => "S300" "fechaPublicacion" => "2018-12-01" "aid" => "1889" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2018;109:929-32" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 8 "formatos" => array:2 [ "HTML" => 6 "PDF" => 2 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731018300310" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.09.021" "estado" => "S300" "fechaPublicacion" => "2018-12-01" "aid" => "1889" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2018;109:929-32" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 399 "formatos" => array:2 [ "HTML" => 298 "PDF" => 101 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científico-clínica</span>" "titulo" => "Dermatitis urticante. Un patrón de reacción cutánea" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "929" "paginaFinal" => "932" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Urticarial Dermatitis. A Cutaneous Reaction Pattern" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 686 "Ancho" => 900 "Tamanyo" => 176662 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Epidermis normal e infiltrado perivascular linfocitario denso con abundantes eosinófilos. Unión dermoepidérmica preservada (tinción hematoxilina-eosina, ampliación original ×<span class="elsevierStyleHsp" style=""></span>20).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.C. García del Pozo, I. Poveda, P. Álvarez, J.F. Silvestre" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M.C." "apellidos" => "García del Pozo" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Poveda" ] 2 => array:2 [ "nombre" => "P." "apellidos" => "Álvarez" ] 3 => array:2 [ "nombre" => "J.F." "apellidos" => "Silvestre" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219018303615" "doi" => "10.1016/j.adengl.2018.10.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018303615?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018300310?idApp=UINPBA000044" "url" => "/00017310/0000010900000010/v1_201812060614/S0001731018300310/v1_201812060614/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219018303639" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.10.009" "estado" => "S300" "fechaPublicacion" => "2018-12-01" "aid" => "1930" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2018;109:933-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Three Cases of Scalp Sarcoidosis with Alopecia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "933" "paginaFinal" => "934" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tres casos de sarcoidosis del cuero cabelludo con alopecia" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 879 "Ancho" => 1750 "Tamanyo" => 440271 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical and histological characteristics of scalp sarcoidosis (hematoxylin-eosin staining, original magnification ×200). A and B, Case 1. C and D, Case 2. E and F, Case 3.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Ishikawa, M. Ohtsuka, T. Yamamoto" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Ishikawa" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Ohtsuka" ] 2 => array:2 [ "nombre" => "T." "apellidos" => "Yamamoto" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018300929" "doi" => "10.1016/j.ad.2017.11.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018300929?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018303639?idApp=UINPBA000044" "url" => "/15782190/0000010900000010/v1_201812060634/S1578219018303639/v1_201812060634/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219018303603" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.10.006" "estado" => "S300" "fechaPublicacion" => "2018-12-01" "aid" => "1968" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2018;109:927-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1 "PDF" => 1 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Simultaneous Disappearance of Various Nevi in a Patient with Autoimmune Disorders" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "927" "paginaFinal" => "928" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Desaparición simultánea de nevus en un paciente con procesos autoinmunes asociados" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1050 "Ancho" => 1400 "Tamanyo" => 179741 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical and dermoscopic images showing changes in the patient's nevi.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P.J. Álvarez-Chinchilla, I. Poveda Montoyo, B. Encabo-Durán, J. Bañuls Roca" "autores" => array:4 [ 0 => array:2 [ "nombre" => "P.J." "apellidos" => "Álvarez-Chinchilla" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Poveda Montoyo" ] 2 => array:2 [ "nombre" => "B." "apellidos" => "Encabo-Durán" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Bañuls Roca" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018302060" "doi" => "10.1016/j.ad.2017.09.027" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018302060?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018303603?idApp=UINPBA000044" "url" => "/15782190/0000010900000010/v1_201812060634/S1578219018303603/v1_201812060634/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Urticarial Dermatitis. A Cutaneous Reaction Pattern" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">To the Editor:</span>" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "929" "paginaFinal" => "932" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M.C. García del Pozo, I. Poveda, P. Álvarez, J.F. Silvestre" "autores" => array:4 [ 0 => array:4 [ "nombre" => "M.C." "apellidos" => "García del Pozo" "email" => array:1 [ 0 => "sakuragarciadelpozo@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "I." "apellidos" => "Poveda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "P." "apellidos" => "Álvarez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "J.F." "apellidos" => "Silvestre" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Complejo Hospitalario Universitario de Albacete, Albacete, España" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital General de Alicante–ISABIAL, Alicante, España" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dermatitis urticante. Un patrón de reacción cutánea" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1326 "Ancho" => 1050 "Tamanyo" => 138515 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A, Excoriated erythematous papules on the back of a patient. B, Use of the Fric test to confirm dermographism on the back of a patient with prurigo lesions at different stages of progression.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In 2006, Kossard and coworkers coined the term <span class="elsevierStyleItalic">urticarial dermatitis</span> (UD) to describe a histological skin reaction pattern with a broad clinical spectrum. UD is primarily characterized by the presence of urticarial, erythematous, pruritic papules or plaques and eczematous lesions.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> Biopsy of urticarial areas reveals a normal stratum corneum, minimal spongiosis, and perivascular lymphocytic infiltrate of the papillary dermis with eosinophils (with or without neutrophils)<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). In this descriptive observational study we describe the clinical and histological findings in 6 patients with a diagnosis suggestive of UD who were treated at the Eczema Unit of the Dermatology Service of a tertiary hospital in 2015 and 2016. <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> shows corresponding data on epidemiology, comorbidities, clinical presentation, initial clinical suspicion, diagnostic tests, final diagnosis, disease duration at the time of diagnosis, follow-up period, treatment, and progression.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">The mean age at UD onset was 70 years (range, 45–88 years). None of the patients had a personal or family history of atopy, urticaria, or any other skin disease. All patients reported having pruritus and in all cases physical examination confirmed the presence of urticarial papules or plaques and clinical signs of dermatitis (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>A). Dermographism was detected in 4 patients (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>B). The initial clinical suspicions included UD, chronic spontaneous urticaria (CSU), bullous pemphigoid, and eczema. Other clinical entities included in the differential diagnosis were drug reactions, urticaria-vasculitis, scabies, and dermatitis herpetiformis.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">In all cases, a final diagnosis was established based on the results of diagnostic tests (CSU in 3 patients, drug reaction in 2 patients, and Schnitzler syndrome in 1 patient). The mean time from disease onset to final diagnosis was 7 months (range, 3–13 months) and the mean duration of follow-up was 11.3 months (range, 5–20 months). All patients were initially treated with oral antihistamines and corticosteroids. Improvement was observed in only 2 patients, both of whom were later diagnosed with CSU. All but 1 patient responded well to targeted treatment once the definitive diagnosis had been established.</p><p id="par0020" class="elsevierStylePara elsevierViewall">UD is not a discrete disorder, but a group of skin diseases that share similar clinical and histological manifestations. In many patients with clinically suspected UD a clinical-pathological correlation can be reached through accurate diagnostic assessment,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a> although this can take several months. Pathologists have used the term <span class="elsevierStyleItalic">dermal hypersensitivity reaction pattern</span> to describe UD, despite the absence of a clinical or histological correlation between these presentations.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">1,3</span></a> All cases in this series initially posed a diagnostic challenge, as none could be classified as a specific inflammatory disorder. Ultimately, a final diagnosis was established in all cases. The most common diagnosis was CSU, followed by drug reaction. Our results differ from those previously reported in the literature: Kossard and coworkers found that the most frequent clinical associations were eczema and drug reactions,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> while 47% of the cases in the series by Hannon and coworkers were of idiopathic origin.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a> Certain histological clues may facilitate the establishment of a more specific diagnosis,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a> particularly if observed in earlier disease stages when the lesions are more edematous and less excoriated. The presence of spongiosis supports a diagnosis of eczema, while its absence is suggestive of urticaria or lesions secondary to either drug reaction or urticaria.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> Because UD can constitute the initial signs of bullous pemphigoid,<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">1,2</span></a> it is advisable to perform direct immunofluorescence studies.</p><p id="par0025" class="elsevierStylePara elsevierViewall">UD typically affects elderly patients, especially women.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">2,4</span></a> Because many patients are polymedicated, it can be difficult to identify the causative agent in cases of suspected drug-induced UD. UD lesions have a polymorphous appearance, and exhibit features of urticaria and concomitant or simultaneous dermatitis.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a> Eczematous lesions may be caused in part by the use of home remedies to relieve itching. In our study, physical examination revealed dermographism in some patients. Although dermographism is typical of drug reaction, scabies and, above all, CSU, its presence can be particularly helpful in the diagnosis of UD.</p><p id="par0030" class="elsevierStylePara elsevierViewall">UD may involve a T helper 2 (Th2) lymphocyte reaction, which precedes a dominant T helper 1 (Th1) cytokine profile, particularly in cases of atopic dermatitis.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">1,5</span></a> This induces the production of interleukin (IL)-4, IL-5, and IL-10, all of which can give rise to eosinophilia and urticarial reactions.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">The therapies most commonly used to treat UD include oral antihistamines, topical and systemic corticosteroids, narrowband ultraviolet B radiation, and topical calcineurin inhibitors, usually with unsatisfactory results.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">1,2,4</span></a> Some reports have described good responses to treatment with other therapeutic agents, including cyclosporins, mycophenolate mofetil, azathioprine, dapsone, and hydroxyurea.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">3,6</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">In conclusion, UD is a common manifestation of several distinct skin diseases that appear to share a similar pathophysiological mechanism. A final diagnosis can be established after exhaustive evaluation of the information obtained from anamnesis, histology, and other additional tests. The detection of dermographism in the physical examination may help orient the diagnosis towards UD. However, this finding should not be considered a specific sign of any condition in particular. In our opinion, UD is a useful term to describe a skin reaction mainly observed in the elderly, the clinical characteristics of which mimic those of several skin diseases. In many cases, a definitive diagnosis can only be established after long-term follow up.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0045" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of Interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: García del Pozo MC, Poveda I, Álvarez P, Silvestre JF. Dermatitis urticante. Un patrón de reacción cutánea. Actas Dermosifiliogr. 2018;109:929–932.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 686 "Ancho" => 900 "Tamanyo" => 176662 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Normal epidermis and dense perivascular lymphocytic infiltrate with abundant eosinophils. Preserved dermoepidermal junction (hematoxylin-eosin, original magnification ×20).</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1326 "Ancho" => 1050 "Tamanyo" => 138515 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A, Excoriated erythematous papules on the back of a patient. B, Use of the Fric test to confirm dermographism on the back of a patient with prurigo lesions at different stages of progression.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: BP, bullous pemphigoid; BPH, benign prostatic hyperplasia; BT, blood test; CBC, complete blood count; CSU, chronic spontaneous urticaria; DIF, direct immunofluorescence; DM, diabetes mellitus; DR, drug reaction; GF, glomerular filtrate; MTX, methotrexate; N/A, not applicable; NSAIDs, non-steroidal anti-inflammatory drugs; OA, oral antihistamines; OC, oral corticosteroids; TC, topical corticosteroids; UD, urticarial dermatitis; WM, Waldenström macroglobulinemia.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Female \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Male \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Female \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Male \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Female \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Female \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age, y \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">71 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">88 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">62 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">77 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">45 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">77 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Comorbidities \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">DM<br>Dyslipidemia<br>Essential hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">BPH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Dyslipidemia<br>DM \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">DM<br>BPH<br>Ischemic heart disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">DM<br>Osteoporosis<br>WM<br>Ovarian teratoma \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dermographism \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">+ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">+ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">- \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">- \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">+ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">+ \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Initial clinical suspicion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Scabies<br>Eczema<br>BP<br>UD<br>CSU \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">BP<br>Eczema<br>UD<br>CSU \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">UD<br>CSU<br>Urticaria-vasculitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Allergic contact dermatitis<br>UD<br>BP<br>DR \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Scabies<br>Eczema<br>CSU<br>Dermatitis herpetiformis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">CSU<br>Urticaria-vasculitis DR<br>BP \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Histology \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal epidermis<br>Superficial dermal perivascular, lymphocytic, and eosinophilic infiltrate with presence of eosinophils<br>DIF– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Focal parakeratosis, mild eosinophilic spongiosis, and poor vacuolization of the basement membrane Superficial perivascular lymphocytic infiltrate<br>Interstitial lymphocytic and eosinophilic infiltrate<br>DIF– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal epidermis<br>Superficial dermal perivascular, lymphocytic, and eosinophilic infiltrate with interstitial eosinophils<br><br>DIF– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal epidermis<br>Superficial dermal perivascular, lymphocytic, and eosinophilic infiltrate<br>DIF– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal epidermis<br>Superficial dermal perivascular, lymphocytic, and eosinophilic infiltrate with interstitial eosinophils<br>DIF– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal epidermis<br>Mild dermal edema, superficial and interstitial dermal perivascular, lymphocytic, and neutrophilic infiltrate without eosinophils<br>No signs of vasculitis<br>DIF– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Other diagnostic tests \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">BT (IgE, 260 IU/mL;<br>eosinophils, 0.86 × 10<span class="elsevierStyleSup">3</span>/μL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Patch test (negative) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">BT:<br>normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">BT (glucose, 195<span class="elsevierStyleHsp" style=""></span>mg/dL; GF, 52 mL/min; CBC, normal) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Final diagnosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">UD (DR secondary to vildagliptin) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">CSU<br> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">CSU<br> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">UD (DR secondary to silodosin) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">CSU<br> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Schnitzler syndrome \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Permethrin<br>OA<br>OC<br>TC<br>MTX<br>Vildagliptin (interrupted) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">OA<br>OC<br>TC<br><br> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">OA<br>OC<br>NSAIDs (interrupted)<br> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">OA<br>OC<br>TC<br>Silodosin (interrupted)<br> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Permethrin<br>OA<br>OC<br>TC<br>Montelukast Omalizumab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">OA<br>OC<br>TC<br>MTX \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Treatment response \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Good \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Good \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Good \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Good \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Good \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Poor<br> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Delay between onset and diagnosis, mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Follow-up, mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1915245.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Descriptive Data: Patient Characteristics, Clinical Presentation, and Treatment.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0035" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Defining urticarial dermatitis. A subset of dermal hypersensitivity reaction pattern" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Kossard" 1 => "I. Hamann" 2 => "B. Wilkinson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archderm.142.1.29" "Revista" => array:6 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2006" "volumen" => "142" "paginaInicial" => "29" "paginaFinal" => "34" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16415383" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0040" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Urticarial dermatitis: Clinical features, diagnostic evaluation, and etiologic associations in a series of 146 patients at Mayo Clinic (2006-2012)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.R. Hannon" 1 => "D.A. Wetter" 2 => "L.E. Gibson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2013.08.050" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2014" "volumen" => "70" "paginaInicial" => "263" "paginaFinal" => "268" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24268310" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0045" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The clinical and histopathologic spectrum of “dermal hypersensitivity reactions” a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a “dermal hypersensitivity reaction pattern”" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.A. Fung" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1067/mjd.2002.120908" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2002" "volumen" => "47" "paginaInicial" => "898" "paginaFinal" => "907" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12451376" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0050" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Retrospective chart review in a cohort of patients with urticarial dermatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Banan" 1 => "G. Butler" 2 => "J. Wu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Australas J Dermatol" "fecha" => "2014" "volumen" => "55" "paginaInicial" => "137" "paginaFinal" => "139" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0055" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: An immunocytochemical study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Thepen" 1 => "E.G. Langeveld-Wildschut" 2 => "I.C. Bihari" 3 => "D.F. van Wichen" 4 => "F.C. van Reijsen" 5 => "G.C. Mudde" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "1996" "volumen" => "97" "paginaInicial" => "828" "paginaFinal" => "837" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8613640" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0060" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mycophenolate mofetil as a treatment of urticarial dermatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Chaptini" 1 => "S. Sidhu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ajd.12192" "Revista" => array:6 [ "tituloSerie" => "Australas J Dermatol" "fecha" => "2014" "volumen" => "55" "paginaInicial" => "275" "paginaFinal" => "278" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25178716" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000010/v1_201812060634/S1578219018303615/v1_201812060634/en/main.assets" "Apartado" => array:4 [ "identificador" => "6157" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case and Research Letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000010/v1_201812060634/S1578219018303615/v1_201812060634/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018303615?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 27 | 14 | 41 |
2024 Octubre | 148 | 80 | 228 |
2024 Septiembre | 162 | 67 | 229 |
2024 Agosto | 188 | 73 | 261 |
2024 Julio | 137 | 67 | 204 |
2024 Junio | 131 | 77 | 208 |
2024 Mayo | 159 | 75 | 234 |
2024 Abril | 134 | 50 | 184 |
2024 Marzo | 140 | 54 | 194 |
2024 Febrero | 106 | 54 | 160 |
2024 Enero | 113 | 64 | 177 |
2023 Diciembre | 94 | 53 | 147 |
2023 Noviembre | 134 | 75 | 209 |
2023 Octubre | 98 | 84 | 182 |
2023 Septiembre | 91 | 94 | 185 |
2023 Agosto | 105 | 59 | 164 |
2023 Julio | 88 | 79 | 167 |
2023 Junio | 64 | 62 | 126 |
2023 Mayo | 79 | 81 | 160 |
2023 Abril | 75 | 50 | 125 |
2023 Marzo | 109 | 53 | 162 |
2023 Febrero | 87 | 48 | 135 |
2023 Enero | 69 | 70 | 139 |
2022 Diciembre | 53 | 75 | 128 |
2022 Noviembre | 38 | 49 | 87 |
2022 Octubre | 28 | 53 | 81 |
2022 Septiembre | 34 | 65 | 99 |
2022 Agosto | 37 | 57 | 94 |
2022 Julio | 33 | 69 | 102 |
2022 Junio | 31 | 57 | 88 |
2022 Mayo | 86 | 82 | 168 |
2022 Abril | 132 | 66 | 198 |
2022 Marzo | 138 | 63 | 201 |
2022 Febrero | 138 | 47 | 185 |
2022 Enero | 155 | 77 | 232 |
2021 Diciembre | 117 | 41 | 158 |
2021 Noviembre | 126 | 62 | 188 |
2021 Octubre | 117 | 77 | 194 |
2021 Septiembre | 133 | 103 | 236 |
2021 Agosto | 158 | 89 | 247 |
2021 Julio | 124 | 69 | 193 |
2021 Junio | 84 | 64 | 148 |
2021 Mayo | 150 | 67 | 217 |
2021 Abril | 353 | 118 | 471 |
2021 Marzo | 154 | 46 | 200 |
2021 Febrero | 145 | 60 | 205 |
2021 Enero | 116 | 34 | 150 |
2020 Diciembre | 99 | 31 | 130 |
2020 Noviembre | 66 | 24 | 90 |
2020 Octubre | 79 | 30 | 109 |
2020 Septiembre | 81 | 38 | 119 |
2020 Agosto | 43 | 26 | 69 |
2020 Julio | 59 | 25 | 84 |
2020 Junio | 50 | 29 | 79 |
2020 Mayo | 27 | 20 | 47 |
2020 Abril | 21 | 19 | 40 |
2020 Marzo | 28 | 8 | 36 |
2020 Febrero | 1 | 1 | 2 |
2019 Abril | 6 | 2 | 8 |